MeVis Medical Solutions Unveils Strong H1 2023/2024 Financial Results

• MeVis Medical Solutions AG announced its results for the first half of fiscal year 2023/2024 - Revenue for the first half of the year was €8,774k, with 27% from licenses, 35% from maintenance revenue, and 38% from other revenue - Earnings before interest and taxes (EBIT) increased to €2,735k with an EBIT margin of 24% - Income from loans of financial assets was €643k, resulting in earnings before taxes (EBT) of €2,735k - Net income for the year was €0k, with a forecast of sales to increase slightly to between €18.0m and €18.5m for the full year - The Executive Board will review expectations throughout the fiscal year based on current business performance

The next important date, Publication of the semi-annual financial report, at MeVis Medical Solutions is on 27.05.2024.

The price of MeVis Medical Solutions at the time of the news was 26,50EUR and was up +1,15 % compared with the previous day.

MeVis Medical Solutions

0,00 %

-0,75 %

-0,75 %

+8,20 %

-13,16 %

-19,51 %

-10,81 %

-48,11 %

ISIN:DE000A0LBFE4WKN:A0LBFE

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max